<DOC>
	<DOCNO>NCT01541475</DOCNO>
	<brief_summary>The current study conduct patient major depression . The study aim 1 ) investigate combine effect selective serotonin reuptake inhibitor ( SSRI ) bupropion compare SSRI alone improvements depressive symptom , fatigue , hypersomnia , neurocognitive function , 2 ) observe structural/functional/chemical change use magnetic resonance imaging ( MRI ) , 3 ) examine relationship improvement depressive symptom , fatigue , hypersomnia neural change .</brief_summary>
	<brief_title>Neuroimaging Study Bupropion Treatment Patients With Major Depressive Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Men woman age 20 65 Diagnosis major depressive disorder ( MDD ) assess Structured Clinical Interview DSMIV ( SCIDIV ) Individuals provide write consent participation . Presence major physical neurological illness ( e.g. , head trauma , epilepsy , seizure , stroke , cerebral tumor , multiple sclerosis , cerebrovascular disease , narrowangle glaucoma , drug hypersensitivity , etc . ) Diagnosis Axis I disorder MDD presence symptom require hospitalization Intelligence quotient ( IQ ) 80 Contraindications magnetic resonance imaging ( e.g. , pacemaker implantation , claustrophobia , etc . ) Unstable medical illness abnormality observe screen laboratory test Women pregnant , breastfeeding , plan pregnancy Allergy tolerance clinical trial medication Presence physical illness contraindicate clinical trial medication ( e.g. , epilepsy , history uncontrollable narrowangle glaucoma ) Use psychoactive medication may affect brain imaging finding</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>